YF-452
YF-452 is a potent inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2) . YF-452 remarkably inhibits the migration, invasion and tube-like structure formation of human umbilical vein endothelial cells (HUVECs) with little toxicity. YF-452 inhibits VEGF-induced phosphorylation of VEGFR2 kinase and the downstream protein kinases including extracellular signal regulated kinase (ERK), focal adhesion kinase (FAK) and Src. YF-452 is a potential antiangiogenic agent candidate for cancer research[1].
Product Specifications
CAS Number
1951466-83-3
UNSPSC
12352005
Target
VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-programmed cell death
Field of Research
Cancer; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/yf-452.html
Solubility
10 mM in DMSO
Smiles
BrC1=CC=C(CN(C2=C3C=CC=C2)C4=C3CCN(C4)C(CN5CCCC5)=O)C=C1
Molecular Formula
C24H26BrN3O
Molecular Weight
452.39
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
VEGFR2/KDR/Flk-1
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
2- ((((9H-fluoren-9-yl) methoxy) carbonyl) amino) -5-methylbenzoic acid
Recombinant Human Beta-defensin 121 (DEFB121)
Recombinant Human Beta-defensin 121 (DEFB121)
Recombinant Human Beta-defensin 121 (DEFB121)